Between 2013 and 2023, the market value per capita for opacifying preparations for X-Ray and diagnostic reagents in Belgium displayed a consistent downward trend. From $11.53 in 2013, it decreased annually to $5.01 by 2023. Key year-on-year declines were noted, especially in 2022 (-11.31%) and 2023 (-7.40%). The Compound Annual Growth Rate (CAGR) from 2018 to 2023 was approximately -6.30%, highlighting a significant five-year negative trend. This continuous decline reflects changing market dynamics, potential shifts in healthcare spending, or technological advancements reducing individual costs.
Future trends to monitor include:
- Technological innovations impacting diagnostic imaging.
- Potential regulatory changes affecting market pricing.
- Shifts in healthcare priorities or budgeting that might stabilize or reverse the negative trend.
| # | 24 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 South Korea | 9.87 | 2023 | View data | ||
| 2 | 2 Italy | 9.66 | 2023 | View data | ||
| 3 | 3 Greece | 8.33 | 2023 | View data | ||
| 4 | 4 Australia | 7.28 | 2023 | View data | ||
| 5 | 5 Austria | 6.83 | 2023 | View data | ||
| 8 | 8 Spain | 5.61 | 2023 | View data | ||
| 9 | 9 Finland | 5.16 | 2023 | View data | ||
| 10 | 10 Belgium | 5.01 | 2023 | |||
| 11 | 11 Croatia | 4.7 | 2023 | View data | ||
| 12 | 12 United Kingdom | 3.89 | 2023 | View data | ||
